Metraipolis › archive › dc_44779ed484c5

Circulating tumour cell-derived xenograft as a preclinical platform for metastatic breast cancer — Europe PMC PMID:42151560

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42151560
DOI
10.1038/s41416-[numero omesso]-0
License (as archived)
solo-consultazione
Archived
2026-11-01T15:40:18.278Z
SHA-256 of the archived text
ef98ea5d7cad255606a7eb1af4998a4b7206f9b99c2ee8041b68f2dc32276074
Stable URL of this page
https://metraipolis.com/documento/dc_44779ed484c5

How to cite

Circulating tumour cell-derived xenograft as a preclinical platform for metastatic breast cancer — Europe PMC PMID:42151560 — Europe PMC (en), https://europepmc.org/article/MED/42151560 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_44779ed484c5 (Metraipolis archive dc_44779ed484c5, sha256 ef98ea5d7cad255606a7eb1af4998a4b7206f9b99c2ee8041b68f2dc32276074)
BibTeX
@misc{dc44779ed484c5,
  title = {Circulating tumour cell-derived xenograft as a preclinical platform for metastatic breast cancer — Europe PMC PMID:42151560},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42151560},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_44779ed484c5; sha256 ef98ea5d7cad255606a7eb1af4998a4b7206f9b99c2ee8041b68f2dc32276074},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42151560. Agents can read the archived copy with the MCP tool read_document.